[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100641810":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":30,"responsibleParty":44,"collaborators":10,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":10,"eligibilityCriteria":51,"healthyVolunteers":48,"sex":52,"minAge":53,"maxAge":10,"enrollmentInfo":54,"targetDuration":10,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":10,"overallStatus":61,"whyStopped":10,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},{"fullName":5,"class":6},"Novo Nordisk A\u002FS","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Cohort 1",null,"Adults with haemophilia A with and without inhibitors",[13],"Other: No treatment given",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"OTHER","No treatment given","Web-based survey",[9],[21],{"name":22,"affiliation":5,"role":23},"Clinical Transparency (dept. 2834)","STUDY_DIRECTOR",[25],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Novo Nordisk","CONTACT","(+1) 866-867-7178","clinicaltrials@novonordisk.com",[31],{"facility":32,"status":10,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":10},"Novo Nordisk Investigational Site","Mainz","Gonsenheim","55124","Germany","DE",{"type":39,"coordinates":40},"Point",[41,42],8.28008,49.98185,{"lat":42,"lon":41},{"type":45,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100641810","patient-preferences-in-treatment-of-haemophilia-a-with-and-without-inhibitors-a-discrete-choice-experiment-in-germany-100641810",false,"NCT07653139","Patient Preferences in Treatment of Haemophilia A With and Without Inhibitors: a Discrete Choice Experiment in Germany","Inclusion Criteria:\n\n* Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).\n* Participant has the mental capacity and sufficient German language proficiency to understand the study procedures and to complete the survey.\n* Age above or equal to 18 years at the time of signing informed consent.\n* Validated diagnose with haemophilia A, with and without inhibitors.\n* Resident in Germany.\n\nExclusion Criteria:\n\n* No provision of informed consent in this study.\n* Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation\n* Age below 18 years at the time of signing informed consent.\n* Absence of a diagnosis of haemophilia A.\n* No residence in Germany.","ALL","18 Years",{"count":55,"type":56},150,"ESTIMATED","OBSERVATIONAL","This study aims to generate structured patient preference evidence on prophylactic treatment options for haemophilia A for adults with and without inhibitors to support health technology assessment and benefit evaluation processes. The study will examine how individuals with haemophilia A evaluate trade-offs between treatment effectiveness, safety, and treatment administration characteristics when choosing between prophylactic therapies. Participants will repeatedly choose between hypothetical treatment profiles that differ in clinically relevant attributes and levels.",[60],"Haemophilia A","NOT_YET_RECRUITING","2026-06-11",{"date":64,"type":65},"2026-06-17","ACTUAL",{"date":67,"type":56},"2026-07-10",{"date":69,"type":56},"2026-10-26",{"name":5,"class":6},1]